ResearcherSHOWA Medical UniversityNo recent work listed
Keiichiro Yoneyama
Matched on OpenAlex author ID A5112084350.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers
Papers 3
- Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer. Co-author DOI 10.1007/s00280-015-2887-4↗
- Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1. Co-author PMID 25916086↗
- Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine therapy. First author DOI 10.5754/hge11567↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yuji Kiuchi · 3 shared papers, 2012–2015
- Paper Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer. DOI 10.1007/s00280-015-2887-4↗
- Paper Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1. PMID 25916086↗
- Paper Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine the… DOI 10.5754/hge11567↗
- Tatsuya Kurihara · 3 shared papers, 2012–2015
- Paper Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer. DOI 10.1007/s00280-015-2887-4↗
- Paper Practical prognostic index for survival in patients with unresectable pancreatic cancer treated with gemcitabine or S-1. PMID 25916086↗
- Paper Factors predicting the appearance of neutropenia in patients with advanced pancreatic cancer undergoing gemcitabine the… DOI 10.5754/hge11567↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.